English 中国科学院 联系我们  
 
站内检索
 您现在的位置:首页 > 新闻中心 > 媒体扫描
【上海日报】Danshen sales top US$4.9b annually
发表日期: 2014-10-23
打印 关闭 浏览次数:
       By Cai Wenjun | October 23, 2014, Thursday

  MORE than 30 billion yuan (US$4.9 billion) worth of Danshen products were sold annually in China, accounting for one third of the market for cardiovascular products.

  A new drug with effective ingredients from Danshen, or saliva, developed by the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences saw 3.5 billion yuan in sales last year, local experts told the 28th International Symposium on the Chemistry of Natural Products in Shanghai yesterday, which was World Traditional Medicine Day.

  Though there is a huge market for traditional Chinese medicine in China, it is not recognized in the West.

  "It is important to transfer TCM from an experience-based medicine to an evidence-based medicine,” said Guo De’an from the Shanghai institute. "Quality control, safety, efficacy and mechanism are the key to industrialization and internationalization of TCM. We must build a TCM standard recognized internationally.”

评 论
  版权所有 中国科学院上海药物研究所 沪ICP备05005386号-1
地址: 上海市浦东张江祖冲之路555号 邮编:201203 电话: 86-21-50806600

沪公网安备 31011502008305号